First humans test new fatty liver injection
NCT ID NCT05599945
Summary
This early-stage study tested the safety of a single injection of a new experimental drug called NNC0581-0001. It involved 48 healthy adults and people with fatty liver disease to see how their bodies handled the drug and to check for side effects. The main goal was to gather initial safety data, not to treat the liver condition.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Parexel CPRU, Level 7
Harrow, Middlesex, HA1 3UJ, United Kingdom
-
Parexel Research Unit
Harrow, Middlesex, HA1 3UJ, United Kingdom
Conditions
Explore the condition pages connected to this study.